Northwest Biotherapeutics Inc (NASDAQ:NWBO)

8.47
Delayed Data
As of Apr 24
 -0.15 / -1.74%
Today’s Change
3.79
Today|||52-Week Range
9.45
+58.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues0.000.000.00872.0K
 
 
Depreciation And Amortization3.0K3.0K346.0K--
 
 
 
 
 
Operating ExpensesGross Income-3.0K-3.0K-346.0K872.0K
 
 
 
 
 
General Expenses23.7M25.4M26.8M26.6M
 
 
 
 
 
Research And Development20.0M21.5M22.7M21.4M
 
 
 
 
 
Total Operating Expenses23.7M25.4M27.2M26.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.7M-25.4M-27.2M-25.8M
 
 
 
 
 
Extraordinary Credit--4.7M14.0M449.0K
 
 
 
 
Extraordinary Charge-22.2M-5.1M---17.2M
 
 
 
 
Interest Expense On Debt122.0K33.0K271.0K570.0K
 
 
 
 
 
Other Expenses-2.0K0.00-7.6M0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-46.0M-25.9M-21.0M-42.7M
 
 
 
 
 
Net Income-46.0M-25.9M-21.0M-42.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS52.4M57.4M60.6M65.7M
 
 
 
 
 
Shares To Calculate EPS Diluted52.4M57.4M60.6M65.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.88-$0.45-$0.35-$0.65
 
 
 
 
 
EPS Diluted-$0.88-$0.45-$0.35-$0.65
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account